This is a demo store. No orders will be fulfilled.

Tilogotamab (anti-TNFRSF10B) - Primary antibody, specific to TNFRSF10B, Human IgG1

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab209738
Grouped product items
SKU Size
Availability
Price Qty
Ab209738-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab209738-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$519.90
Ab209738-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,299.90
Ab209738-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,079.90

Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Tilogotamab (anti-TNFRSF10B) - Primary antibody, specific to TNFRSF10B, Human IgG1
Synonyms Fas like protein antibody | Apoptosis inducing protein TRICK2A/2B antibody | Apoptosis inducing receptor TRAIL R2 antibody | CD262 antibody | CD262 antigen antibody | Hx-DR5-01/05 | HexaBody-DR5/DR5 | GEN-1029 | ZTNFR9 | tumor necrosis factor receptor-lik
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Biochemical and Physiological Mechanisms Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade
Host species Human
Specificity TNFRSF10B
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Product Description

Tilogotamab (anti-TNFRSF10B) is an agonistic hexamer formation-enhanced mixture of two antibodies that target two separate epitopes on death receptor type 5 (DR5). Tilogotamab (anti-TNFRSF10B) specifically binds to and activates DR5. Tilogotamab (anti-TNFRSF10B) can be used for the research of multiple myeloma (MM).

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 145.18 kDa
Purification Method Protein A purified
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2109731-10-2

Associated Targets(Human)

TNFRSF10B Tbio Tumor necrosis factor receptor superfamily member 10B (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Tilogotamab (anti-TNFRSF10B) (Ab209738) - ELISA
Immobilized Recombinant Human TRAIL R2/TNFRSF10B protein (rp176693) at 1.0 μg/mL can bind Tilogotamab (anti-TNFRSF10B) (Ab209738) with the EC₅₀ of 22.13 ng/mL.

Tilogotamab (anti-TNFRSF10B) (Ab209738) - SEC
The purity of Tilogotamab (anti-TNFRSF10B) (Ab209738) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.